Pierre Fabre Laboratories Announce IND Filing for PFL-002 / VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell Lung Cancer with MET Alterations

Pierre Fabre Italy United States of America Canada France Germany Spain United Kingdom

View original content:https://www.prnewswire.co.uk/news-releases/pierre-fabre-laboratories-announce-ind-filing-for-pfl-002vert-002-a-potential-treatment-for-patients-with-solid-tumors-including-non-small-cell-lung-cancer-with-met-alterations-302163756.html